Zkusit zdarma
Sutro Biopharma, Inc.

Sutro Biopharma, Inc.

STRO
Cena:
$ 25.57
-5.05 (-16.49%)
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

16:05 14-05-2026

– On track to report initial safety, PK and early activity from Phase 1 dose-escalation trial of S...

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

19:45 19-04-2026

STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid t...

Sutro Biopharma (NASDAQ:STRO) Trading 10.4% Higher on Analyst Upgrade

Sutro Biopharma (NASDAQ:STRO) Trading 10.4% Higher on Analyst Upgrade

1:00 18-04-2026

Sutro Biopharma, Inc. (NASDAQ: STRO - Get Free Report)'s stock price traded up 10.4% on Friday after...

Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?

Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?

9:36 08-04-2026

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume....

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

16:05 23-03-2026

– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC...

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

8:25 11-02-2026

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume....

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

7:00 10-02-2026

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the C...

Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?

Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?

7:16 22-01-2026

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume....

Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

16:46 15-01-2026

Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript...

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of “Hold” by Analysts

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of “Hold” by Analysts

1:38 02-01-2026

Sutro Biopharma, Inc. (NASDAQ: STRO - Get Free Report) has been given a consensus recommendation of ...

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Brokerages

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Brokerages

1:28 08-12-2025

Shares of Sutro Biopharma, Inc. (NASDAQ: STRO - Get Free Report) have received a consensus recommend...

Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript

Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript

18:22 12-11-2025

Sutro Biopharma, Inc. ( STRO ) Discusses Strategic Reset and Progress in Next-Generation ADC Pipelin...

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates

19:26 06-11-2025

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.67 per share versus the Zacks Cons...

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights

16:30 06-11-2025

– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004,...

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

16:05 05-11-2025

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the C...

Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones

Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones

17:05 29-09-2025

– Extends cash runway into at least mid-2027 – SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOB...

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates

18:51 07-08-2025

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.14 per share versus the Zacks Cons...

Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights

16:30 07-08-2025

– On track to initiate FIH study with STRO-004, potential best-in-class Tissue Factor ADC, in the ...

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates

18:56 08-05-2025

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.91 per share versus the Zacks Cons...

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

16:31 08-05-2025

- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review...

close

SUTRO BIOPHARMA ANNOUNCES PRICING OF $110.0 MILLION UNDERWRITTEN OFFERING

10-02-2026
SOUTH SAN FRANCISCO, CALIF., FEB. 10, 2026 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-11-2025
– COMPANY ANNOUNCES U.S. FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR STRO-004,...
Více zde

SUTRO BIOPHARMA TO HOST VIRTUAL RESEARCH & DEVELOPMENT DAY ON NOVEMBER 12, 2025

05-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 05, 2025 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA ANNOUNCES PARTICIPATION AT THE 16TH ANNUAL WORLD ADC CONFERENCE

03-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 03, 2025 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA ANNOUNCES OPERATIONAL RESTRUCTURING INTENDED TO EXTEND CASH RUNWAY THROUGH KEY MILESTONES

29-09-2025
– EXTENDS CASH RUNWAY INTO AT LEAST MID-2027 – SOUTH SAN FRANCISCO, CALIF., SEPT. 29, 2025 (GLOB...
Více zde

SUTRO BIOPHARMA REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-08-2025
– ON TRACK TO INITIATE FIH STUDY WITH STRO-004, POTENTIAL BEST-IN-CLASS TISSUE FACTOR ADC, IN THE ...
Více zde

SUTRO BIOPHARMA REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

08-05-2025
- SHARPENED PRODUCT CANDIDATE FOCUS ON ITS NEXT-GENERATION ADC PORTFOLIO, FOLLOWING STRATEGIC REVIEW...
Více zde

SUTRO BIOPHARMA TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

01-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 01, 2025 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE CO...
Více zde

SUTRO BIOPHARMA TO HIGHLIGHT ITS NEXT-GENERATION EXATECAN AND DUAL-PAYLOAD ADC PROGRAMS IN PRESENTATIONS AT AACR 2025

28-04-2025
- PRECLINICAL FINDINGS SHOW STRO-004'S PROMISING ANTI-TUMOR ACTIVITY AND FAVORABLE SAFETY PROFILE - ...
Více zde

SUTRO BIOPHARMA PRESENTS DATA FROM DOSE-OPTIMIZATION PORTION OF REFRΑME-O1 TRIAL IN PATIENTS WITH PLATINUM RESISTANT OVARIAN CANCER AT SGO 2025

15-03-2025
- THE LATE-BREAKING ORAL PRESENTATION AT SGO 2025 HIGHLIGHTS CONSISTENT RESPONSE RATES OBSERVED IN P...
Více zde

SUTRO BIOPHARMA REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

13-03-2025
– SUTRO ANNOUNCED A STRATEGIC PORTFOLIO REVIEW RESULTING IN PRIORITIZATION OF WHOLLY-OWNED NEXT-GE...
Více zde

SUTRO BIOPHARMA ANNOUNCES STRATEGIC PORTFOLIO REVIEW RESULTING IN THE PRIORITIZATION OF ITS NEXT-GENERATION ADC PIPELINE

13-03-2025
– SUTRO WILL RAPIDLY ADVANCE NEXT-GENERATION EXATECAN AND DUAL-PAYLOAD ADC PROGRAMS; LUVELTAMAB TA...
Více zde

SUTRO BIOPHARMA TO PRESENT AT THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE

03-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 03, 2025 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE ...
Více zde

SUTRO BIOPHARMA TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 07, 2025 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

13-11-2024
- EXPECTS TO DELIVER THREE INVESTIGATIONAL NEW DRUG (IND) APPLICATIONS IN NEXT THREE YEARS BASED ON ...
Více zde

SUTRO BIOPHARMA DEMONSTRATES MEANINGFUL ADC INNOVATION WITH FIVE PRESENTATIONS AT THE 15TH ANNUAL WORLD ADC CONFERENCE

04-11-2024
SOUTH SAN FRANCISCO, CALIF., NOV. 04, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA ANNOUNCES INITIATION OF THE REGISTRATION-ENABLING REFRΑME-P1 TRIAL WITH LUVELTA FOR PEDIATRIC PATIENTS WITH CBF/GLIS AML

01-11-2024
SOUTH SAN FRANCISCO, CALIF., NOV. 01, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA HIGHLIGHTS NEXT-GENERATION ADC INNOVATION AND NEAR-TERM PIPELINE AT RESEARCH FORUM

10-10-2024
PROPRIETARY CELL-FREE PLATFORM ENABLES THE DESIGN OF NEXT-GENERATION ADCS INTENDED TO BROADEN ADDRES...
Více zde

SUTRO BIOPHARMA ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

20-09-2024
SOUTH SAN FRANCISCO, CALIF., SEPT. 20, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE ...
Více zde

SUTRO BIOPHARMA ANNOUNCES UPDATED DATA FROM PHASE 1B STUDY OF LUVELTA IN COMBINATION WITH BEVACIZUMAB AT ESMO 2024

14-09-2024
- 4.3 MG/KG OF LUVELTAMAB TAZEVIBULIN (LUVELTA) IN COMBINATION WITH STANDARD DOSE OF BEVACIZUMAB (15...
Více zde

SUTRO BIOPHARMA TO HOST RESEARCH FORUM HIGHLIGHTING NEXT-GENERATION ADC INNOVATION AND NEAR-TERM PIPELINE, ON OCTOBER 10, 2024

11-09-2024
SOUTH SAN FRANCISCO, CALIF., SEPT. 11, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE ...
Více zde

SUTRO BIOPHARMA ANNOUNCES INITIATION OF REFRΑME-L1 PHASE 2 TRIAL WITH LUVELTA FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER

22-08-2024
SOUTH SAN FRANCISCO, CALIF., AUG. 22, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

SUTRO BIOPHARMA REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS, BUSINESS HIGHLIGHTS AND SELECT ANTICIPATED MILESTONES

13-08-2024
- SUTRO WILL PRESENT UPDATED DATA FROM THE ONGOING PHASE 1B STUDY OF LUVELTA IN COMBINATION WITH BEV...
Více zde

VGXI INC. ANNOUNCES A STRATEGIC PARTNERSHIP WITH SUTRO BIOPHARMA INC. TO SUPPORT GROWING CLINICAL PIPELINE

03-06-2024
CONROE, TEXAS , JUNE 3, 2024 /PRNEWSWIRE/ -- VGXI, INC., A LEADING CONTRACT DEVELOPER AND MANUFACTUR...
Více zde

SUTRO BIOPHARMA REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS, BUSINESS HIGHLIGHTS AND SELECT ANTICIPATED MILESTONES

13-05-2024
- INVESTIGATIONAL NEW DRUG APPLICATION FOR NON-SMALL CELL LUNG CANCER TRIAL WITH LUVELTA CLEARED BY ...
Více zde

SUTRO BIOPHARMA ANNOUNCES INITIATION OF RANDOMIZED PORTION (PART 2) OF REFRΑME-O1 TRIAL

30-04-2024
– PART 2 OF REFRΑME-O1, THE REGISTRATION-DIRECTED STUDY OF LUVELTA FOR PATIENTS WITH PLATINUM-RES...
Více zde

SUTRO BIOPHARMA ANNOUNCES PRICING OF $75 MILLION UNDERWRITTEN OFFERING

02-04-2024
SOUTH SAN FRANCISCO, CALIF., APRIL 02, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE ...
Více zde

IPSEN AND SUTRO BIOPHARMA ANNOUNCE EXCLUSIVE GLOBAL LICENSING AGREEMENT FOR AN ADC TARGETING SOLID TUMORS

02-04-2024
PARIS, FRANCE; SAN FRANCISCO, U.S., 02 APRIL 2024 - IPSEN (EURONEXT: IPN; ADR: IPSEY) AND SUTRO BIOP...
Více zde

SUTRO BIOPHARMA REPORTS FULL YEAR 2023 FINANCIAL RESULTS, BUSINESS HIGHLIGHTS AND SELECT ANTICIPATED MILESTONES

25-03-2024
- SUTRO HIGHLIGHTED LUVELTAMAB TAZEVIBULIN (LUVELTA) IN A JANUARY 2024 INVESTOR WEBCAST, DESCRIBING ...
Více zde

SUTRO BIOPHARMA TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

06-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 06, 2024 (GLOBE NEWSWIRE) -- SUTRO BIOPHARMA, INC. (SUTRO OR THE C...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-10 00:00:008-KStáhnout
2025-12-17 00:00:008-KStáhnout
2025-12-03 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-25 01:00:008-KStáhnout
2025-06-25 00:00:008-KStáhnout
2025-06-10 01:00:008-KStáhnout
2025-06-10 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-04-14 01:00:008-KStáhnout
2025-04-14 00:00:008-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-13 00:00:0010-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-12 23:00:0010-KStáhnout
2024-12-10 00:00:008-KStáhnout
2024-12-09 23:00:008-KStáhnout
2024-11-13 00:00:008-KStáhnout
2024-11-13 00:00:0010-QStáhnout
2024-11-12 23:00:008-KStáhnout
2024-11-12 23:00:0010-QStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 00:00:008-KStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-05-13 01:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:008-KStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-04-02 01:00:008-KStáhnout
2024-04-02 00:00:008-KStáhnout
2024-03-25 00:00:008-KStáhnout
2024-03-25 00:00:0010-KStáhnout
2024-03-24 23:00:008-KStáhnout
2024-03-24 23:00:0010-KStáhnout
2024-02-09 00:00:008-KStáhnout
2024-02-08 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-11-21 00:00:008-KStáhnout
2023-11-20 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-04 01:00:008-KStáhnout
2023-10-04 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-26 01:00:008-KStáhnout
2023-06-26 00:00:008-KStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-04-14 01:00:008-KStáhnout
2023-04-14 00:00:008-KStáhnout
2023-03-30 01:00:008-KStáhnout
2023-03-30 01:00:0010-KStáhnout
2023-03-30 00:00:008-KStáhnout
2023-03-30 00:00:0010-KStáhnout
2023-02-24 00:00:008-KStáhnout
2023-02-23 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-20 00:00:008-KStáhnout
2022-12-19 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-10-24 01:00:008-KStáhnout
2022-10-24 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-26 01:00:008-KStáhnout
2022-07-26 00:00:008-KStáhnout
2022-06-28 01:00:008-KStáhnout
2022-06-28 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-20 01:00:008-KStáhnout
2022-04-20 00:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-12-27 00:00:008-KStáhnout
2021-12-26 23:00:008-KStáhnout
2021-11-17 00:00:008-KStáhnout
2021-11-16 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-09-30 01:00:008-KStáhnout
2021-09-30 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-19 01:00:008-KStáhnout
2021-05-19 00:00:008-KStáhnout
2021-05-07 01:00:008-KStáhnout
2021-05-07 01:00:0010-QStáhnout
2021-05-07 00:00:008-KStáhnout
2021-05-07 00:00:0010-QStáhnout
2021-04-15 01:00:008-KStáhnout
2021-04-15 00:00:008-KStáhnout
2021-03-18 00:00:008-KStáhnout
2021-03-18 00:00:0010-KStáhnout
2021-03-17 23:00:008-KStáhnout
2021-03-17 23:00:0010-KStáhnout
2020-12-09 00:00:008-KStáhnout
2020-12-08 23:00:008-KStáhnout
2020-12-07 00:00:008-KStáhnout
2020-12-06 23:00:008-KStáhnout
2020-12-04 00:00:008-KStáhnout
2020-12-03 23:00:008-KStáhnout
2020-12-01 00:00:008-KStáhnout
2020-11-30 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-09-09 01:00:008-KStáhnout
2020-09-09 00:00:008-KStáhnout
2020-09-04 01:00:008-KStáhnout
2020-09-04 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-15 01:00:008-KStáhnout
2020-06-15 00:00:008-KStáhnout
2020-06-05 01:00:008-KStáhnout
2020-06-05 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-11 01:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:008-KStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-04-27 01:00:008-KStáhnout
2020-04-27 00:00:008-KStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2020-03-03 00:00:008-KStáhnout
2020-03-02 23:00:008-KStáhnout
2020-01-08 00:00:008-KStáhnout
2020-01-07 23:00:008-KStáhnout
2019-11-08 00:00:008-KStáhnout
2019-11-08 00:00:0010-QStáhnout
2019-11-07 23:00:008-KStáhnout
2019-11-07 23:00:0010-QStáhnout
2019-10-30 00:00:008-KStáhnout
2019-10-29 23:00:008-KStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 01:00:0010-QStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-14 00:00:0010-QStáhnout
2019-06-24 01:00:008-KStáhnout
2019-06-24 00:00:008-KStáhnout
2019-06-17 01:00:008-KStáhnout
2019-06-17 00:00:008-KStáhnout
2019-06-10 01:00:008-KStáhnout
2019-06-10 00:00:008-KStáhnout
2019-05-15 01:00:008-KStáhnout
2019-05-15 01:00:0010-QStáhnout
2019-05-15 00:00:008-KStáhnout
2019-05-15 00:00:0010-QStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 00:00:008-KStáhnout
2019-04-01 01:00:008-KStáhnout
2019-04-01 01:00:0010-KStáhnout
2019-04-01 00:00:008-KStáhnout
2019-04-01 00:00:0010-KStáhnout
2018-11-15 00:00:008-KStáhnout
2018-11-14 23:00:008-KStáhnout
2018-11-14 00:00:0010-QStáhnout
2018-11-13 23:00:0010-QStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-07 23:00:008-KStáhnout
preloader